Precision Peptide Company
Public Markets

Market Access, Reimagined.

The Precision Peptide Company is a public wellness platform building high-quality USA-made peptide formulations, delivery systems, and scalable consumer access.

Canadian Securities Exchange
CSE: BPC
Over-the-Counter Markets
OTCQB: PNGAF

Investor materials and news releases are provided for informational purposes and should be read alongside the Company's public filings.

Press Releases

Latest Market Updates

Recent news releases for BPC.NE. Expand each item for a concise release summary.

Precision Peptide Company

Innovation Leadership

Pratap Sandhu
Pratap Sandhu
Chief Executive Officer

Entrepreneur and former pro athlete innovating at the intersection of human performance and medicine, driven to make breakthrough health solutions accessible at scale.

Matt Stang
Matt Stang
Co-Founder, Chief Visionary Officer

Built High Times into a cultural icon, driving cannabis normalization and creating platforms that reshaped the industry. Brings deep experience in brand building and market creation.

Justin Kirkland
Justin Kirkland
Co-Founder, Chief Scientific Officer

A longevity medicine expert with 30+ years in drug development and pharmaceutical innovation. A patent holder and founder of multiple pharmaceutical companies, Justin drives breakthroughs in personalized medicine and longevity.

Barbara Branaman
Barbara Branaman
Co-Founder, Principal Innovator

Co-founded BioReset Medical, leading growth in regenerative care with deep expertise in operations and health innovation.

Eric Ulwelling
Eric Ulwelling
Chief Financial Officer

A CPA and financial leader with 15+ years of experience guiding companies through growth, restructuring, and capitalization.

Investor Deck

Current Investor Presentation

Review the May 2026 investor deck directly on this page, or open the PDF in a separate tab for a full-screen view.